[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-343099-105":3,"doc-detail-343099-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","molecular-characterization-and-xenotransplantation-of-pancreatic-cancer-using-endoscopic-ultrasound-guided-fine-needle-aspiration-eus-fna","Molecular Characterization and Xenotransplantation of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA)","","Pancreatic cancer has an extremely poor prognosis and limited treatment choices, driven in part by strong genetic diversity between patients. Patient-derived xenografts enable more tailored tumor characterization and therapeutic development, while endoscopic ultrasound fine-needle aspiration (EUS-FNA) offers a minimally invasive tissue source alternative to surgery. In 30 Ottawa Hospital patient cases, EUS-FNA supported xenotransplantation in NOD-SCID mice, genetic testing, marker studies, and sequencing readiness.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/molecular-characterization-and-xenotransplantation-of-pancreatic-cancer-using-endoscopic-ultrasound-guided-fine-needle-aspiration-eus-fna/343099/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/molecular-characterization-and-xenotransplantation-of-pancreatic-cancer-using-endoscopic-ultrasound-guided-fine-needle-aspiration-eus-fna/343099.png","ImageObject",300,407,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are patient-derived xenografts important for pancreatic cancer research?","Question",{"text":63,"@type":64},"They help perform genetic and therapeutic testing on human tumor tissue and support more personalized characterization while reducing patient exposure to therapy-related side effects.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was EUS-FNA used in the study?",{"text":68,"@type":64},"EUS-FNA samples were collected from 30 patients and used for xenotransplantation in NOD-SCID mice as well as genetic analyses.",{"name":70,"@type":61,"acceptedAnswer":71},"What outcomes did the study report for xenograft establishment and sequencing?",{"text":72,"@type":64},"The xenograft take rate was 75.9% for passage 1 and 100% for passage 2, and 80% of patient tumor samples were successfully sequenced to high depth for 42 cancer genes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},343099,1790142530,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c",8,"cancers   \nArticle  \nMolecular Characterization and Xenotransplantation of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA)  \nLilia Antonova 1,*, Piriya Paramanthan 2, Theresa Falls 3, Marie-Eve Wedge 3, Justin Mayer 3, Harman S. Sekhon 4, John McPherson 5, Robert E. Denroche 5, Steven Gallinger 5, John Cameron Bell 3, Carolina S. Ilkow 3 and Avijit Chatterjee 2  \nCitation: Antonova, L.; Paramanthan, P.; Falls, T.; Wedge, M.-E.; Mayer, J.; Sekhon, H.S.; McPherson, J.;  \nDenroche, R.E.; Gallinger, S.; Bell, J.C.; et al. Molecular Characterization and Xenotransplantation of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) . Cancers 2024, 16, 2721. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/cancers16152721](10.3390/cancers16152721)  \nAcademic Editor: Louis Buscail  \nReceived: 28 June 2024  \nRevised: 21 July 2024  \nAccepted: 25 July 2024  \nPublished: 31 July 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Otolaryngology-Head and Neck Surgery, University of Ottawa, Ottawa, ON K1N 6N5, Canada  \n2 Division of Gastroenterology, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada  \n3 Centre for Cancer Therapeutics, Ottawa Health Research Institute, Ottawa, ON K1H 8L6, Canada  \n4 Division of Anatomic Pathology, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada; [hsekhon@toh.on.ca](hsekhon@toh.on.ca)  \n5 Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada  \n* Correspondence: [lantonova@ohri.ca](lantonova@ohri.ca)  \nSimple Summary: Existing treatments for pancreatic cancer have limited effectiveness due to the genetic diversity between pancreatic tumors from different patients. By propagating the original tumor into a mouse (creating a xenograft) it may be possible to study each individual tumor further and plan personalized therapy. EUS-FNA is a technique which has recently become a routine method for obtaining a biopsy from a patient without the need for surgery. In this study, we tested whether EUS-FNA can also be used to obtain tumor tissue of sufficient volume and purity to establish a corresponding xenograft and to perform a genetic analysis. We found that in the majority of cases, both mouse xenografts and genetic analyses can be performed successfully. Xenograft tumors were found to maintain the characteristics and genetic expression from the original patient tumors and tobe vulnerable to infection by a virus used to destroy cancer cells.  \nAbstract: Pancreatic cancer has one of the worst prognoses among all malignancies and few available treatment options. Patient-derived xenografts can be used to develop personalized therapy for pancreatic cancer. Endoscopic ultrasound fine-needle aspiration (EUS-FNA) may provide a powerful alternative to surgery for obtaining sufficient tissue for the establishment of patient-derived xenografts. In this study, EUS-FNA samples were obtained for 30 patients referred to the Ottawa Hospital, Ottawa, Ontario, Canada. These samples were used for xenotransplantation in NOD-SCID mice and for genetic analyses. The gene expression of pancreatic-cancer-relevant genes in xenograft tumors was examined by immunohistochemistry. Targeted sequencing of both the patient-derived tumorsand xenograft tumors was performed. The xenografts’ susceptibility to oncolytic virus infection was studied by infecting xenograft-derived cells with VSV∆51-GFP. The xenograft take rate was found to be 75.9% for passage 1 and 100% for passage 2 . Eighty percent of patient tumor samples were successfully sequenced to a high depth for 42 cancer genes. Xenograft histological characteristics and marker e","cbCaivU9JsvVhwoW","https://ap.wps.com/l/cbCaivU9JsvVhwoW","pdf",3590342,18,"English","# Abstract\n## Methods and sampling\n## Xenotransplantation and genetic analyses\n## Virus susceptibility and outcomes\n## Conclusions","[{\"question\":\"Why are patient-derived xenografts important for pancreatic cancer research?\",\"answer\":\"They help perform genetic and therapeutic testing on human tumor tissue and support more personalized characterization while reducing patient exposure to therapy-related side effects.\"},{\"question\":\"How was EUS-FNA used in the study?\",\"answer\":\"EUS-FNA samples were collected from 30 patients and used for xenotransplantation in NOD-SCID mice as well as genetic analyses.\"},{\"question\":\"What outcomes did the study report for xenograft establishment and sequencing?\",\"answer\":\"The xenograft take rate was 75.9% for passage 1 and 100% for passage 2, and 80% of patient tumor samples were successfully sequenced to high depth for 42 cancer genes.\"}]","Molecular Characterization and Xenotransplantation of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) | PDF",1790049866,45,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8657a2a1dbb59ad6317b98d4ee7d2f7a.webp",983,1390,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f562f50caea226ef94a050adf835d31b.webp",982,1388,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f3ffeddd9e5f7945f7dc01d4b7747cad.webp",981,1387,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bd2ef4ad9514f09e050b08751d6bf65.webp",980,1385,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,145,148,152,155,159],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":142,"show_sort_weight":143,"slug":144},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":146,"slug":147},30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":149,"show_sort_weight":150,"slug":151},"Religion & Spirituality",20,"religion-spirituality",{"id":150,"doc_module":4,"doc_module_name":25,"category_name":153,"show_sort_weight":150,"slug":154},"World Cup","world-cup",{"id":156,"doc_module":4,"doc_module_name":25,"category_name":157,"show_sort_weight":156,"slug":158},10,"Lifestyle","lifestyle",{"id":160,"doc_module":4,"doc_module_name":25,"category_name":161,"show_sort_weight":131,"slug":162},19,"General","general"]